pembrolizumab,pds0101
merck,pds biotech
['keytruda', 'pds0101', '$pdsb']
$pdsb post asco presentation recap of versatile-002 - historical keytruda: orr 17%, overall survival at 12 mos 49% - keytruda+pds0101:orr 41.2%, overall survival at 9 mos 89% 
Clinical pharmacist PharmD, BCPS | Not advice, just my opinions and a lot of dabble about Biotech | Tech | Defi (3, 3)